Skip to main content

31 July 2026

Last updated: Friday 31 July 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The risks of therapeutic genome editing

Sunday 25 June 2017

Interviewee/Contributor

Houria Bachtarzi and Tim Farries

Organisation

ERA Consulting (UK) Ltd

Organisations

Fraunhofer Institute for Systems and Innovation Research
ST&I Partners LLP
Scancell Holdings Plc
Purespring Therapeutics Ltd
Zealand Pharma A/S
Themis Bioscience GmbH
Forbion Capital Partners
Symphogen A/S
Pharmatching GmbH
RhoVac AB

Interviewees and Contributers

João Ribas and Morten Graugaard Døssing
Mark Vaeck
Steven Powell
Martin Fussenegger
Richard Jones and Stephen Witte
Tarek Samad
Richard Holland
Keith Thompson
Nigel Gaymond
Gabriele Schaffner-Dallmann

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form